← Back to Search

High risk + multi-fact for Shingles

N/A

Recruiting

Led By Christopher F Chabris, PhD

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up in the 14 months following enrollment

Awards & highlights

Study Summary

This trial aims to see if sending messages to patients to ask about the Shingrix vaccine will help increase vaccination rates. They will also determine which message version works the best.

Who is the study for?

This trial is for individuals aged 50 or older who haven't had the Shingrix vaccine and have an upcoming non-urgent in-person appointment at a Geisinger primary care facility that has the vaccine available.Check my eligibility

What is being tested?

The study is examining if different types of reminder messages can encourage patients to discuss and potentially receive the Shingrix shingles vaccine during their next doctor's visit.See study design

What are the potential side effects?

Since this trial involves only reminder messages, there are no direct medical side effects. However, participants may experience increased awareness or anxiety about vaccination.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ in the 14 months following enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~in the 14 months following enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and in the 14 months following enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Other outcome measures

Attended scheduled appointment

Completion of Shingrix series

First Shingrix vaccination

+3 more

Trial Design

5Treatment groups

Experimental Treatment

Active Control

Group I: Multi-factExperimental Treatment1 Intervention

Patients in this arm will be sent messages with facts about shingles and Shingrix, and encouraging them to ask about Shingrix at their upcoming appointment.

Group II: High risk + multi-factExperimental Treatment1 Intervention

Patients in this arm will be sent messages informing them that they are at high risk for shingles because they are ages 50+, with additional facts about shingles and Shingrix, and encouraging them to ask about Shingrix at their upcoming appointment.

Group III: High riskExperimental Treatment1 Intervention

Patients in this arm will be sent messages informing them that they are at high risk for shingles because they are ages 50+, and encouraging them to ask about Shingrix at their upcoming appointment.

Group IV: Passive controlActive Control1 Intervention

Patients in this arm will not be sent any messages.

Group V: Active controlActive Control1 Intervention

Patients in this arm will be sent messages encouraging them to ask about Shingrix at their upcoming appointment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Reminder

2022

N/A

~311170

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor

149 Previous Clinical Trials

1,836,135 Total Patients Enrolled

National Bureau of Economic Research, Inc.OTHER

31 Previous Clinical Trials

873,240 Total Patients Enrolled

Massachusetts Institute of TechnologyOTHER

97 Previous Clinical Trials

12,679,987 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the ongoing medical study actively seeking participants at this time?

"Yes, according to clinicaltrials.gov, this investigation is actively seeking volunteers. The trial was initially listed on March 25th, 2024 and most recently revised on the same day. The aim is to recruit a total of 50,000 participants from one designated site."

Answered by AI

How many individuals in total are enrolled as participants in this medical study?

"Affirmative. Records on clinicaltrials.gov highlight the ongoing search for suitable candidates in this medical trial. Initially shared on March 25, 2024, and last revised on the same date, the study aims to recruit a total of 50,000 participants within one designated location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nudging Patients to Increase Shingles Vaccination

Christopher F Chabris, PhD 2024. "Nudging Patients to Increase Shingles Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06238726.

All > Shingles